The rising prevalence in GLP-1 agonists for metabolic health has sparked a debate about formats: skin-applied devices versus capsules. Typically, GLP-1 therapies were solely available in pill form, but https://alexiavmkq189244.azzablog.com/41399745/glp-1-transdermal-delivery-systems-vs-oral-medications-what-best-for-the-patient